Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
|Articles|June 2, 2015
- Pharmaceutical Technology-06-02-2015
- Volume 39
- Issue 6
Pharmaceutical Technology, June 2015 Issue (PDF)
Click the title above to open the Pharmaceutical Technology June 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 11 years ago
Another In-House Operation Gets Outsourcedover 11 years ago
Quality Systems Key to Lifecycle Drug Managementover 11 years ago
Designing Clean Zonesover 11 years ago
New Ways Around Hazardous Reagent Chemistryover 11 years ago
Industry Expert Q&A with David Fitzhenryover 11 years ago
Unlocking the Vast Potential of PAT in Solid-Dosage Manufacturingover 11 years ago
Top Trends in Biopharmaceutical Manufacturing: 2015over 11 years ago
Preventing Common Mistakes in Automated WashingAdvertisement
Related to this article
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Merck licenses SciBrunch's preclinical KRAS G12D inhibitor for $2.13B, raising tech transfer and scale-up questions for oral cancer drug development.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.
Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Advertisement
Advertisement